Beyond genetics and lifestyle, the gut microbiome is now emerging as an important factor in cancer progression and treatment response. This raises an important question: could understanding and targeting this ecosystem transform the way we treat cancer?
Dietary fiber is often seen as essential for gut health. However, is it always beneficial? New research challenges this idea, highlighting that not all fibers act the same and that context, type, and dose matter.
From diet to microbiome therapies: Key insights from the GMFH Summit 2026
19 May 2026by Manon Oliero, Giovana Martucelli, Andreu Prados
The 14th edition of the Gut Microbiota for Health World Summit brought together leading researchers from around the world to present the latest advances in the field. The meeting reinforced clinical practices that have become increasingly established in recent years and also presented unpublished results on new microbiome-targeted therapies, in line with the summit’s central theme: “Diet and other ways to manipulate the gut microbiome in clinical practice.”
Intermittent fasting has become increasingly popular as a dietary approach for improving metabolic and gut health. This article explores the potential benefits and risks of intermittent fasting for the gut, examining current evidence on its effects on digestion, the gut microbiota, and overall health.
Intermittent fasting and eating rhythmicity: what we know about their impact on metabolic and gut health
2 Mar 2026by Manon Oliero
Much of nutrition science has centred on what we put on our plate, yet when we choose to eat may be just as consequential. Intermittent fasting (IF) has gained attention as a strategy that may support metabolic health while also reshaping microbial rhythms, gut hormone secretion, and intestinal function. The growing interest surrounding this approach raises an essential question for clinical practice: does IF truly translate into measurable benefits?
After two decades of scientific exploration, the human microbiome has emerged as a critical determinant of health and disease. Fueled by multi-omics technologies and machine learning, the field has advanced from correlation-based observations to establishing causal relationships. This article presents recent and compelling examples of microbiome-based treatments that are ripe for clinical adoption and discusses challenges and opportunities facing the field based on expert interviews conducted by the GMFH team.
A new stool biomarker for multiple sclerosis: gut bacteria’s role in disease progression
13 May 2025by Manon Oliero
New research suggests that changes in the ratio between two common gut bacteria could be associated with symptom severity in people with multiple sclerosis. While more studies are needed, the findings point to a potential microbial marker for monitoring the disease.
Microorganisms in the gut emerge as a potential determining factor for understanding the links between stress response and brain function. New findings highlight the role of gut microbiota as a central regulator of the stress-circadian axis.
Could a simple change in diet transform your gut microbiome and reduce your risk of chronic diseases? This article explores recent research testing a diet inspired by non-industrialized dietary patterns.
We continue our series on the gut axis, this time focusing on the gut-skin connection. You might have noticed it yourself—how a heavy, sugary meal can lead to breakouts the next day, or how certain food allergies can trigger rashes. This is the gut-skin axis at work, demonstrating an association between the health of our gut and the condition of our skin, and vice versa.
